ERYTECH Pharma S.A.
Develops red blood cell-based therapies for cancer and orphan diseases.
ERYP | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417360 (+2 more)
- LEI:
- 969500U8ZZCODU8A9374
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://phaxiam.com/
- Sector:
- Manufacturing
Description
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company that develops innovative therapeutics based on its proprietary ERYCAPS platform, which encapsulates drug substances inside red blood cells. This technology is designed to improve the efficacy and safety of treatments by prolonging the drug's circulation time and reducing side effects. The company's primary focus is on developing treatments for severe forms of cancer and orphan diseases. Its lead product candidate, eryaspase, encapsulates the enzyme L-asparaginase to starve cancer cells of essential nutrients, targeting indications such as acute lymphoblastic leukemia and pancreatic cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-05-12 14:46 |
Franchissement de seuils
|
French | 371.8 KB | ||
| 2021-05-11 10:21 |
Franchissement de seuils et déclaration d'intention
|
French | 385.7 KB | ||
| 2021-05-10 12:00 |
Franchissements de seuils et déclaration d'intention
|
French | 385.6 KB | ||
| 2021-05-07 18:00 |
Information mensuelle relative au nombre total de droits de vote et d’actions c…
|
French | 209.2 KB | ||
| 2021-05-07 18:00 |
Monthly information related to total number of voting rights and shares composi…
|
English | 118.1 KB | ||
| 2021-05-06 14:54 |
Franchissement de seuil
|
French | 205.3 KB | ||
| 2021-05-05 08:07 |
Franchissement de seuils
|
French | 202.5 KB | ||
| 2021-05-04 22:30 |
ERYTECH fait le point sur ses activités et publie ses résultats financiers du p…
|
French | 419.5 KB | ||
| 2021-05-04 22:30 |
ERYTECH Provides Business Update and Reports Financial Results for the First Q…
|
English | 408.9 KB | ||
| 2021-04-29 08:30 |
ERYTECH Announces $30.0 Million Registered Direct Offering
|
English | 263.0 KB | ||
| 2021-04-29 08:30 |
ERYTECH annonce la levée de 30 millions de dollars dans le cadre d’une register…
|
French | 301.4 KB | ||
| 2021-04-29 01:30 |
ERYTECH annonce sa position de trésorerie au 31 mars 2021 et les détails de par…
|
French | 245.8 KB | ||
| 2021-04-29 01:30 |
ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its…
|
English | 247.9 KB | ||
| 2021-04-20 07:30 |
ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in…
|
English | 255.6 KB | ||
| 2021-04-20 07:30 |
ERYTECH sollicite une réunion auprès de la FDA en amont de sa demande de BLA af…
|
French | 247.0 KB |
Automate Your Workflow. Get a real-time feed of all ERYTECH Pharma S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ERYTECH Pharma S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ERYTECH Pharma S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-06-23 | N/A | Other | Other | 3,697,533 | 2,255,495.13 EUR |
| 2023-06-23 | N/A | Other | Other | 71,839 | 43,821.79 EUR |
| 2023-06-23 | N/A | Other | Other | 54,862 | 33,465.82 EUR |
Peer Companies
